1. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (ADHD);Álamo;Actas Esp Psiquiatr,2016
2. ANSM [Internet] [cité 7 avril 2024]. Liste des spécialités en accès dérogatoire – Strattera. Disponible sur : https://ansm.sante.fr/tableau-acces-derogatoire/strattera.
3. Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline;Banaschewski;Eur Child Adolesc Psychiatry,2006
4. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder;Bond;Ann Clin Psychiatry,2012
5. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study;Chen;PLoS One,2018